Transitions in decision-making authority at the end of life: a problem of law, ethics and practice in deceased donation.
Decision-making
Donation/Procurement of Organs/Tissues
End-of-life
Ethics
Law
Journal
Journal of medical ethics
ISSN: 1473-4257
Titre abrégé: J Med Ethics
Pays: England
ID NLM: 7513619
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
09
06
2020
revised:
12
10
2020
accepted:
13
10
2020
pubmed:
29
11
2020
medline:
3
2
2022
entrez:
28
11
2020
Statut:
ppublish
Résumé
Where a person is unable to make medical decisions for themselves, law and practice allows others to make decisions on their behalf. This is common at the end of a person's life where decision-making capacity is often lost. A further, and separate, decision that is often considered at the time of death (and often preceding death) is whether the person wanted to act as an organ or tissue donor. However, in some jurisdictions, the lawful decision-maker for the donation decision (the 'donation decision-maker') is different from the person who was granted decision-making authority for medical decisions during the person's life. To date, little attention has been given in the literature to the ethical concerns and practical problems that arise where this shift in legal authority occurs. Such a change in decision-making authority is particularly problematic where premortem measures are suggested to maximise the chances of a successful organ donation. This paper examines this shift in decision-making authority and discusses the legal, ethical and practical implications of such frameworks.
Identifiants
pubmed: 33246994
pii: medethics-2020-106572
doi: 10.1136/medethics-2020-106572
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
112-117Informations de copyright
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: S-NT and DM were members of the Australia National Health and Medical Research Council’s (NHMRC) Organ and Tissue Working Committee.DM has received consultancy fees from the Australian Organ and Tissue Authority (AOTA). The views presented here are the authors’ own.